For the safety of our patients, in the management of emergency department patients with acute or chronic non-cancer pain,

Size: px
Start display at page:

Download "For the safety of our patients, in the management of emergency department patients with acute or chronic non-cancer pain,"

Transcription

1 BACKGROUND Overdose deaths involving prescription opioid analgesics are rising at a startling rate in the United States. Between 1999 and 2010, reported deaths involving opioid analgesics quadrupled (4,030 to 16,651) 1,2. Over the same period, the yearly number of opioid prescriptions dispensed by retail pharmacies in the U.S. increased from 120 to 210 million and evidence suggests that the increased number of prescriptions has directly contributed to the number of opioid related deaths 3,4. Data specific to Hawaii is limited. However, according to records from the Medical Examiner s Office in the City & County of Honolulu, prescription opioid medications were involved in 36 of 106 drug-related deaths on Oahu in The CDC estimates 5% of Hawaii s population over the age of 11 used prescription opioids for non-medical reasons in Nationally, emergency physicians provide less than 5% of the total number of opioid prescriptions 5,6. However, we witness the effects of opioid misuse on a daily basis as we care for patients who have intentionally or unintentionally overdosed on opioid medications. We are also acutely aware that many use the emergency department as a place to inappropriately obtain prescription opioid medications for diversion or misuse. In response to the epidemic of prescription opioid abuse, multiple government and nongovernment organizations have issued opioid prescribing guidelines Early evidence suggests that such guidelines may reduce the number of opioid prescriptions and inappropriate emergency department visits 11,12. The Hawaii Chapter of the American College of Emergency Physicians created these guidelines to ensure and protect the appropriate use of prescription opioid medications, while attempting to reduce opioid abuse and diversion in the state of Hawaii. Our guidelines are not intended for patients in palliative care programs or for patients with cancer pain, nor do they replace clinical judgment in the care of the individual patient. These guidelines were adopted and modified for Hawaii primarily from the Washington Emergency Department Opioid Prescribing Guidelines published by the Washington Chapter of the American College of Emergency Physicians and the New York City Emergency Department Discharge Opioid Prescribing Guidelines 7,9.

2 RECOMMENDATIONS For the safety of our patients, in the management of emergency department patients with acute or chronic non-cancer pain, 1. Consider short-acting opioid analgesics for the treatment of acute pain only when the severity of the pain is reasonably assumed to warrant their use. Opioid analgesics should not necessarily be considered the primary approach to pain management. With consideration to their inherent risks, alternative and effective pharmacological interventions for acute pain include non-steroidal antiinflammatory drugs (NSAIDs), acetaminophen, and nerve blocks (e.g. for dental pain). Non-pharmacological therapies, such as fracture immobilization and proper elevation of injured extremities, may obviate the need for additional pain medications. Short-acting opioid analgesics such as hydrocodone, immediaterelease oxycodone, and hydromorphone may be considered as adjuncts to relieve acute pain when the severity of the pain warrants their use or when non-opioid medications have not provided adequate relief from pain. 2. If opioid analgesics are prescribed, use the lowest possible safe and effective dose. Higher doses of opioid medications and long-acting opioid medications increase the risk of unintentional overdose and death The risks of opioid use and addiction should be discussed with patients when opioids are prescribed as the initiation of prescription opioid therapy in itself is a risk factor for long term use of narcotic medications Prescribe short courses of opioid analgesics for acute pain. Most patients require no more than three days of medication. Excessive quantities of opioid medications increase the risk of misuse, abuse, and diversion. When prescribed, patients should receive only enough opioid medication from the emergency department (ED) to last them until they are able to see a physician for follow-up care. Further assessment of the patient s pain and appropriate treatment can be made at that time. Some acute conditions in which severe pain is expected to last an extended period of time (e.g. rib fractures) or other extenuating circumstances (e.g. travel, prolonged time to follow-up care) may warrant prescriptions of greater quantities. However, in most cases if the patient s severe pain outlasts an initial three-day prescription, further medical evaluation is warranted to exclude serious complications or the need for further treatment.

3 4. Avoid prescribing long-acting or controlled-release opioid analgesics. Long-acting or controlled-release opioid should only rarely be prescribed from the emergency department, and only in close collaboration with the patient s primary opioid provider. Long-acting and controlled release opioid analgesics are not indicated in the management of acute or intermittent pain. This class of opioid medications may cause fatal respiratory depression when administered to patients not previously exposed to opioids, even when used as directed. Patients being treated with long-acting or controlled-release opioid analgesics for the treatment of pain require close follow-up that cannot be reasonably provided by emergency medical providers. Exceptions may be appropriate for patients in consultation with the patient s primary opioid provider. 5. Consider accessing Hawaii s Prescription Monitoring Program for information on the patient s controlled substance prescription history before providing opioid prescriptions. To assess for opioid abuse or addiction, consider using targeted history or validated screening tools. Patients with a history of substance abuse are at increased risk for developing opioid addiction when prescribed opioid analgesics for acute pain 17,18. Numerous validated screening tools are available, including the DAST-10 (Drug Abuse Screening Test) and the Opioid Risk Tool 19,20. Alternatively, the single question, How many times in the past year have you used an illegal drug or used a prescription medication for non-medical reasons? was found to be 100% sensitive and 74% specific for the detection of a drug use disorder compared to DAST A history of substance abuse in itself should not exclude a patient from prescription opioid medications. However, it should prompt a discussion about the increased risk of addiction. Providers may consider offering non-opioid therapy or reducing the amount of opioid medications prescribed. Referral information for opioid dependence or addiction may also be considered. Hawaii s prescription monitoring database, accessed at the above website, became available to providers in February All prescriptions for controlled substances filled at non-military pharmacies in the state of Hawaii are logged in the database. Currently, prescriptions filled at military facilities are not entered. Providers involved in the patient s care do not need patient permission to access Hawaii s Prescription Monitoring Program. All emergency providers are encouraged to apply to and use the state s monitoring program as a means to gain information regarding a patient s history of controlled substance use before writing prescriptions for opioid medications. An observational study of emergency physician use of the Ohio Automated Rx Reporting System

4 found that physicians changed their opioid prescription plan for 41% of patients after reviewing a patient s prescription history. Among patients whose prescriptions were changed, 61% received fewer or no opioids and 39% received more opioids than originally planned Consider risk factors for respiratory depression and use caution when prescribing opioid analgesics to patients being treated with benzodiazepines or other opioids. More than half of all overdose deaths involving opioid analgesics involve other drugs. Benzodiazepines are the most common class of drug identified with opioid related deaths and are found in 20% of cases 23. Opioid analgesics, when combined with other central nervous system depressants or given to patients with certain underlying medical conditions, can increase the risk for overdose, especially in older patients. Carefully consider the risks and benefits when patients are being treated with both benzodiazepine and opioid medications. The CDC estimates that patients receiving opioids who were prescribed a combination of 100 or more morphine equivalents per day account for 80% of opioid overdoses 24. Opioid analgesics should be used with caution in older patients and those with sleep-disordered breathing, such as sleep apnea, congestive heart failure, or obesity 9. Doses may need to be adjusted in patients with renal or hepatic dysfunction due to decreased clearance. 7. Avoid administering intravenous or intramuscular opioid analgesics for acute exacerbations of chronic pain. Parenteral opioids should generally be avoided for the treatment of chronic pain in the ED because of their short duration of action and potential for addictive euphoria. Generally, oral opioids are superior to parenteral opioids in duration of action and provide a gradual decrease in pain. Parenteral opioids may be appropriate when there is evidence or reasonable suspicion of an acute pathological process causing the acute exacerbation of chronic pain. Under special circumstances some patients may receive intravenous or intramuscular opioids in the ED when an ED care plan is coordinated with the patient s primary care provider. 8. One medical provider should provide all opioid medications to treat a patient s chronic pain. The emergency physician s one-time patient relationship does not allow for proper monitoring of the patient s response to chronic opioid therapy (COT). The American Pain Society states that, Regular monitoring of patients once COT is initiated is critical because therapeutic risks and benefits do not remain static and can be affected by changes in the underlying pain condition, presence of coexisting disease,

5 or changes in psychological or social circumstances. 14 Adding to or changing a patient s COT without contacting the patient s primary opioid provider may place the patient at risk for harm and should be avoided. Opioid prescriptions from the emergency department for exacerbations or progression of chronic pain are discouraged. Patients who require opioid analgesics should obtain opioid prescriptions from a single provider who monitors the patient s pain relief and function. Prescribing opioid analgesics from the emergency department for chronic pain is a form of unmonitored therapy and is not optimal for patient care. Changing a patient s opioid regimen or adding further opioid medications may place the patient at risk and should be avoided. If changes or additions are made, they should be made in consultation with the patient s primary opioid provider. 9. Avoid providing replacement prescriptions for controlled substances that were lost, destroyed, or stolen. Replacement doses of methadone should not be provided in the emergency department. Patients misusing controlled substances frequently report their prescriptions were lost or stolen. Pain specialists routinely stipulate in pain agreements with patients that lost or stolen controlled substances will not be replaced. Emergency departments should maintain a policy to not replace prescriptions for narcotic medications that are lost, stolen, or destroyed. Methadone should not be prescribed or administered as opioid substitution therapy from the ED. Methadone has a long half-life and patients who are part of a daily methadone treatment program and miss a single dose will not go into opioid withdrawal for 48 hours. Furthermore, opioid withdrawal is not an emergency medical condition. The emergency medical provider should consider the patient may have been discharged from a methadone treatment program for noncompliance or is not enrolled. If the patient is admitted to the hospital, the emergency medical provider or admitting physician should call the methadone treatment program to verify the patient s status in a methadone treatment program before initiating methadone therapy. 10. Attempt to coordinate the care of patients who frequently seek care in the ED among emergency, primary care, and specialty providers. Primary care and pain management physicians should make patient pain agreements accessible to local emergency departments and work to include a plan for pain treatment in the ED. Emergency departments should contact the patient s primary provider to notify them of the patient s frequent ED visits and attempt to formulate a care plan. When the patient does not have a primary care provider an ED care plan should be created by an ED physician. This plan should stress the importance of seeing a primary care

6 provider for chronic medical conditions and chronic pain management. The ED care plan should be filed into a dedicated section of the hospital electronic health record. Access to pain management agreements and coordination with the patient s primary opioid provider will help to more safely coordinate the patient s pain management. 11. Provide information about the risks of opioid analgesics, including overdose and addiction, along with information about proper storage and disposal to those receiving a prescription. Patients should be informed of the risks of taking opioid analgesics and be reminded to take them as prescribed. Risks of opioid analgesics include, but are not limited to: overdose that can slow or stop their breathing and lead to death; drowsiness and incoordination leading to injury, especially in those over the age of 60; tolerance; and addiction. Respiratory depression is more common with concurrent use of alcohol, benzodiazepines, antihistamines, and barbiturates. Patients should be reminded to avoid medications that are not part of their treatment plan because they may worsen side effects and increase their risk of overdose. Almost three-quarters (71%) of people aged 12 and older who have used opioid analgesics for nonmedical purposes reported obtaining them free or buying them from family or friends 25. Patients should be instructed how to minimize risks to others by keeping the medication in a secure location, preferably locked, not sharing the medication with anyone, and promptly disposing of unused opioid analgesics by flushing them down the toilet Hospitals are required by law to provide a medical screening examination to determine if a patient has an emergency medical condition. The law does not require physicians to use opioid analgesics to treat pain. The Emergency Medical Treatment and Active Labor Act (EMTALA) requires hospitals to provide a medical screening examination to determine whether an individual presenting to the emergency department has an emergency medical condition. EMTALA does not require the use of opioid medication to treat pain. Providers should apply their professional judgment to determine if opioid analgesics are the appropriate treatment for an individual patient. 1. National Center for Health Statistics. National Vital Statistics Reports, Volume 58, Number 19 (05/20/2010). 2010;: Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, JAMA 2013;309(7): National Institute on Drug Abuse. PrescriptionDrugs: Abuse and Addiction. 2011;:1 16.

7 4. Centers for Disease Control and Prevention (CDC). Vital signs: overdoses of prescription opioid pain relievers---united States, MMWR Morb Mortal Wkly Rep 2011;60(43): Volkow ND, McLellan TA, Cotto JH, Karithanom M, Weiss SRB. Characteristics of opioid prescriptions in JAMA 2011;305(13): Governale L. Outpatient Prescription Opioid Utilization in the U.S., Years [Internet]. Adelphi, MD: Available from: /Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM p df. Accessed 5/10/ Physicians WCOTACOE. Washington Emergency Department Opioid Prescribing Guidelines [Internet]. washingtonacep.org [cited 2013 Apr 18];:1 7. Available from: 8. Agency Medical Directors' Group. Interagency Guideline on Opioid Dosing for Chronic Non-cancer Pain. 2010;: Dowell D. New York City Emergency Department Discharge Opioid Prescribing Guidelines. 2012;: Health UDO. Utah Clinical Guidelines on Prescribing Opioids for Treatment of Pain [Internet]. dopl.utah.gov [cited 2013 May 10];:1 92. Available from: Fox TR, Li J, Stevens S, Tippie T. A Performance Improvement Prescribing Guideline Reduces Opioid Prescriptions for Emergency Department Dental Pain Patients. YMEM 2013;: Franklin G, Mai J, Turner J, Sullivan M, Wickizer T, Fulton-Kehoe D. Bending the prescription opioid dosing and mortality curves: Impact of the Washington State opioid dosing guideline. American Journal of Industrial Medicine 2012;55(4): Bohnert ASB, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 2011;305(13): Chou R, Fanciullo GJ, Fine PG, et al. Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain. The Journal of Pain 2009;10(2):

8 15. Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med 2010;152(2): Alam A, Gomes T, Zheng H, Mamdani MM, Juurlink DN, Bell CM. Long-term analgesic use after low-risk surgery: a retrospective cohort study. Arch Intern Med 2012;172(5): Braden JB, Russo J, Fan M-Y, et al. Emergency department visits among recipients of chronic opioid therapy. Arch Intern Med 2010;170(16): Edlund MJ, Martin BC, DeVries A, Fan M-Y, Braden JB, Sullivan MD. Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study. Clin J Pain 2009;26(1): Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med 2005;6(6): Yudko E, Lozhkina O, Fouts A. A comprehensive review of the psychometric properties of the Drug Abuse Screening Test. Journal of Substance Abuse Treatment 2007;32(2): Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. A single-question screening test for drug use in primary care. Arch Intern Med 2010;170(13): Baehren DF, Marco CA, Droz DE, Sinha S, Callan EM, Akpunonu P. A Statewide Prescription Monitoring Program Affects Emergency Department Prescribing Behaviors. YMEM 2010;56(1):19 23.e National Center for Health Statistics. NCHS Data Brief, Number 22, September ;: Centers for Disease Control and Prevention (CDC). CDC grand rounds: prescription drug overdoses - a U.S. epidemic. MMWR Morb Mortal Wkly Rep 2012;61(1): Studies SOOA. Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings. 2010;: Disposal of Unused Medicines: What You Should Know [Internet]. [cited 2013 May 10]. Available from: fely/ensuringsafeuseofmedicine/safedisposalofmedicines/ucm htm#me DICINES

Arizona s Emergency Department Prescribing Guidelines

Arizona s Emergency Department Prescribing Guidelines Arizona College of Emergency Physicians Arizona State Council Arizona s Emergency Department Prescribing Guidelines Pain is a major symptom of many patients presenting to the emergency department (ED),

More information

Arkansas Emergency Department Opioid Prescribing Guidelines

Arkansas Emergency Department Opioid Prescribing Guidelines Arkansas Emergency Department Opioid Prescribing Guidelines 1. One medical provider should provide all opioids to treat a patient s chronic pain. 2. The administration of intravenous and intramuscular

More information

Prescription Drug Abuse and Overdose: Public Health Perspective

Prescription Drug Abuse and Overdose: Public Health Perspective Prescription Drug Abuse and Overdose: Public Health Perspective [Residency educators may use the following slides for their own teaching purposes.] CDC s Primary Care and Public Health Initiative October

More information

Populations at risk for opioid overdose

Populations at risk for opioid overdose Populations at risk for opioid overdose Len Paulozzi, MD, MPH Division of Unintentional Injury Prevention National Center for Injury Prevention and Control Centers for Disease Control and Prevention April

More information

Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians

Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians Although prescription pain medications are intended to improve the lives of people with pain, their increased use and misuse

More information

CDC s Prevention Efforts to Address Prescription Opioid Epidemic

CDC s Prevention Efforts to Address Prescription Opioid Epidemic CDC s Prevention Efforts to Address Prescription Opioid Epidemic Jan Losby, PhD, MSW Lead, Prescription Drug Overdose Health Systems and State Support Team Division of Unintentional Injury Prevention NASBO

More information

MHA Guidelines for Emergency Department Opioid Management

MHA Guidelines for Emergency Department Opioid Management MHA Guidelines for Emergency Department Opioid Management The Massachusetts Hospital Association Substance Abuse Prevention and Treatment Task Force set a goal to develop provider-focused strategies within

More information

MARYLAND EMERGENCY DEPARTMENT OPIOID PRESCRIBING GUIDELINES

MARYLAND EMERGENCY DEPARTMENT OPIOID PRESCRIBING GUIDELINES MARYLAND EMERGENCY DEPARTMENT OPIOID PRESCRIBING GUIDELINES 1. Hospitals, in conjunction with Emergency Department personnel, should develop a process to screen for substance misuse that includes services

More information

KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE

KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE 201 KAR 9:260. Professional standards for prescribing and dispensing controlled substances.

More information

Considerations when Using Controlled Substances to Treat Chronic Pain

Considerations when Using Controlled Substances to Treat Chronic Pain Considerations when Using Controlled Substances to Treat Chronic Pain By Mary-Beth F. Plum, Pharm.D. Impact of Chronic Pain Acute pain is the body s response to environmental dangers, and it helps protect

More information

Strong States, Strong Nation POLICY OPTIONS TO DECREASE RISKS FROM THE USE OF METHADONE AS A PAIN RELIEVER

Strong States, Strong Nation POLICY OPTIONS TO DECREASE RISKS FROM THE USE OF METHADONE AS A PAIN RELIEVER Strong States, Strong Nation POLICY OPTIONS TO DECREASE RISKS FROM THE USE OF METHADONE AS A PAIN RELIEVER November 17, 2015 Today s Speakers Karmen Hanson, Program Manager, NCSL Cynthia Reilly, Director,

More information

MANAGEMENT OF CHRONIC NON MALIGNANT PAIN

MANAGEMENT OF CHRONIC NON MALIGNANT PAIN MANAGEMENT OF CHRONIC NON MALIGNANT PAIN Introduction The Manitoba Prescribing Practices Program (MPPP) recognizes the important role served by physicians in relieving pain and suffering and acknowledges

More information

MQAC Rules for the Management of Chronic Non-Cancer Pain

MQAC Rules for the Management of Chronic Non-Cancer Pain MQAC Rules for the Management of Chronic Non-Cancer Pain Effective January 2, 2012 246-919-850 Pain management Intent. These rules govern the use of opioids in the treatment of patients for chronic noncancer

More information

Prescription Opioid Overdose & Misuse in Oregon

Prescription Opioid Overdose & Misuse in Oregon Prescription Opioid Overdose & Misuse in Oregon Mel Kohn, MD MPH Public Health Director and State Public Health Officer Oregon Health Authority Oregon In-State Policy Workshop NGA Policy Academy: Reducing

More information

Policy for Prescribing and Dispensing Opioids

Policy for Prescribing and Dispensing Opioids Policy for Prescribing and Dispensing Opioids Colorado Dental Board, Colorado Medical Board, State Board of Nursing, and State Board of Pharmacy In collaboration with the Nurse-Physician Advisory Task

More information

Review of Pharmacological Pain Management

Review of Pharmacological Pain Management Review of Pharmacological Pain Management CHAMP Activities are possible with generous support from The Atlantic Philanthropies and The John A. Hartford Foundation The WHO Pain Ladder The World Health Organization

More information

Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling

Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling Patients with a substance misuse history are at increased risk of receiving inadequate

More information

Implementing Prescribing Guidelines in the Emergency Department. April 16, 2013

Implementing Prescribing Guidelines in the Emergency Department. April 16, 2013 Implementing Prescribing Guidelines in the Emergency Department April 16, 2013 Housekeeping Note: Today s presentation is being recorded and will be provided within 48 hours. Two ways to ask questions

More information

Drug Testing to Support Pain Management

Drug Testing to Support Pain Management NATIONAL REFERENCE LABORATORY Drug Testing to Support Pain Management 500 Chipeta Way, Salt Lake City, UT 84108 (800) 522-2787 (801) 583-2787 www.aruplab.com www.arupconsult.com ARUP is an enterprise of

More information

Abstral Prescriber and Pharmacist Guide

Abstral Prescriber and Pharmacist Guide Abstral Prescriber and Pharmacist Guide fentanyl citrate sublingual tablets Introduction The Abstral Prescriber and Pharmacist Guide is designed to support healthcare professionals in the diagnosis of

More information

Guidelines for Use of Controlled Substances for the Treatment of Pain

Guidelines for Use of Controlled Substances for the Treatment of Pain 1.0 Purpose: Use of Controlled Substances for the Treatment of Pain The Physicians Advisory Committee for Controlled Substances of the Medical Society of Delaware supports the Federation of State Medical

More information

Drug overdose death rates by state per 100,000 people (2008) SOURCE: National Vital Statistics System, 2008

Drug overdose death rates by state per 100,000 people (2008) SOURCE: National Vital Statistics System, 2008 PRESCRITPION DRUG ABUSE: AN EPIDEMIC What is Addiction? By: Lon R. Hays, M.D., M.B.A. Professor and Chairman Department of Psychiatry University of Kentucky Healthcare Addiction is a primary, chronic disease

More information

02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION

02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION Effective June 13, 2010 02-313, 02-373, 02-380, 02-383, 02-396 Chapter 21 page 1 02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION 313 BOARD OF DENTAL EXAMINERS 373 BOARD OF LICENSURE IN MEDICINE

More information

The Journal of the Oklahoma State Medical Association

The Journal of the Oklahoma State Medical Association The Journal of the Oklahoma State Medical Association Opioid Prescribing Guidelines for Oklahoma Health Care Providers in the Office-Based Setting Layne E. Subera, DO; Mark A. Brandenburg, MD; Avy Doran-Redus,

More information

Maximizing Use of Prescription Drug Monitoring Programs

Maximizing Use of Prescription Drug Monitoring Programs Maximizing Use of Prescription Drug Monitoring Programs Christopher M..Jones, PharmD, MPH Division of Unintentional Injury Prevention National Center for Injury Prevention and Control Centers for Disease

More information

PRESCRIPTION PAINKILLER OVERDOSES

PRESCRIPTION PAINKILLER OVERDOSES IMPACT{ POLICY PRESCRIPTION PAINKILLER OVERDOSES National Center for Injury Prevention and Control Division of Unintentional Injury Prevention What s the Issue? In a period of nine months, a tiny Kentucky

More information

Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998

Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998 Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998 Section I: Preamble The New Hampshire Medical Society believes that principles

More information

Testimony of Jeffrey Coben, MD, Director of the West Virginia University Injury Control Research Center before the Senate Finance Committee/Subcommittee on Health Care, on Thursday March 22, 2012 at 10:00

More information

BENZODIAZEPINE CONSIDERATIONS IN WORKERS COMPENSATION: IMPLICATIONS FOR WORK DISABILITY AND CLAIM COSTS By: Michael Erdil MD, FACOEM

BENZODIAZEPINE CONSIDERATIONS IN WORKERS COMPENSATION: IMPLICATIONS FOR WORK DISABILITY AND CLAIM COSTS By: Michael Erdil MD, FACOEM 3 rd Quarter 2015 BENZODIAZEPINE CONSIDERATIONS IN WORKERS COMPENSATION: IMPLICATIONS FOR WORK DISABILITY AND CLAIM COSTS By: Michael Erdil MD, FACOEM Introduction Benzodiazepines, sometimes called "benzos",

More information

HAWAII BOARD OF MEDICAL EXAMINERS PAIN MANAGEMENT GUIDELINES

HAWAII BOARD OF MEDICAL EXAMINERS PAIN MANAGEMENT GUIDELINES Pursuant to section 453-1.5, Hawaii Revised Statutes, the Board of Medical Examiners ("Board") has established guidelines for physicians with respect to the care and treatment of patients with severe acute

More information

WA Opioid Dosing Guidelines Centers for Disease Control 1/14/2009

WA Opioid Dosing Guidelines Centers for Disease Control 1/14/2009 WA Opioid Dosing Guidelines Centers for Disease Control 1/14/2009 Gary M. Franklin, MD, MPH Research Professor Departments of Environmental Health and Neurology University of Washington Medical Director

More information

What you should know about treating your pain with opioids. Important information on the safe use of opioid pain medicine.

What you should know about treating your pain with opioids. Important information on the safe use of opioid pain medicine. What you should know about treating your pain with opioids Important information on the safe use of opioid pain medicine. If your healthcare provider has determined that opioid therapy is right for you,

More information

2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov

2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov OHIO AUTOMATED RX REPORTING SYSTEM 2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov OHIO AUTOMATED RX REPORTING SYSTEM What is OARRS? To address the growing misuse and diversion

More information

Treatment of Chronic Pain: Our Approach

Treatment of Chronic Pain: Our Approach Treatment of Chronic Pain: Our Approach Today s webinar was coordinated by the National Association of Community Health Centers, a partner with the SAMHSA-HRSA Center for Integrated Health Solutions SAMHSA

More information

MSD Guidelines for the Use of Controlled Substances for the Treatment of Pain

MSD Guidelines for the Use of Controlled Substances for the Treatment of Pain GUIDELINES MSD Guidelines for the Use of Controlled Substances for the Treatment of Pain To address the current epidemic of prescription drug abuse, your Medical Society has been working closely with the

More information

Opioids and the Injured Worker Tools for Successful Outcomes

Opioids and the Injured Worker Tools for Successful Outcomes Opioids and the Injured Worker Tools for Successful Outcomes Tim Pokorney, RPh Director, Clinical Express Scripts Workers' Compensation Division Goals and Objectives Alarming statistics for narcotic utilization,

More information

Michigan Guidelines for the Use of Controlled Substances for the Treatment of Pain

Michigan Guidelines for the Use of Controlled Substances for the Treatment of Pain Michigan Guidelines for the Use of Controlled Substances for the Treatment of Pain Section I: Preamble The Michigan Boards of Medicine and Osteopathic Medicine & Surgery recognize that principles of quality

More information

Utah Clinical Guidelines on Prescribing Opioids

Utah Clinical Guidelines on Prescribing Opioids Utah Clinical Guidelines on Prescribing Opioids Presented by: Erin Johnson, MPH January 2009 www.useonlyasdirected.org Overview Utah s prescription problem Why guidelines? Guideline process Guideline content

More information

Prescription Drug Abuse. Katherine E. Schmidt. IHEC Intern - Fall 2010

Prescription Drug Abuse. Katherine E. Schmidt. IHEC Intern - Fall 2010 Disclaimer: The views of the author do not necessarily reflect the views and beliefs of the Illinois Higher Education Center, Eastern Illinois University, and The Department of Human Services. Prescription

More information

Opioids for Pain Treatment. Opioids for Chronic Pain and Addiction Treatment. Outline for Today. Opioids for pain treatment

Opioids for Pain Treatment. Opioids for Chronic Pain and Addiction Treatment. Outline for Today. Opioids for pain treatment Opioids for Chronic Pain and Addiction Treatment Joseph Merrill M.D., M.P.H. University of Washington February 24, 2012 Outline for Today Opioids for pain treatment Trends Problems High dose prescribing

More information

Heroin Addiction. Kim A. Drury RN, MSN

Heroin Addiction. Kim A. Drury RN, MSN Heroin Addiction Kim A. Drury RN, MSN Heroin use is on the rise in our area. Nearly every day the news media reports situations involving Heroin. According to the Substance Abuse and Mental Health Services

More information

UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths

UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths Joanna G Katzman, M.D., M.S.P.H Director, UNM Pain Center Associate Professor,

More information

The Cost of Pain and Economic Burden of Prescription Misuse, Abuse and Diversion. Angela Huskey, PharmD, CPE

The Cost of Pain and Economic Burden of Prescription Misuse, Abuse and Diversion. Angela Huskey, PharmD, CPE The Cost of Pain and Economic Burden of Prescription Misuse, Abuse and Diversion Angela Huskey, PharmD, CPE Case Bill is a 47 year old man with a history of low back pain and spinal stenosis Not a real

More information

OPIOIDS. Petros Levounis, MD, MA Chair Department of Psychiatry Rutgers New Jersey Medical School

OPIOIDS. Petros Levounis, MD, MA Chair Department of Psychiatry Rutgers New Jersey Medical School OPIOIDS Petros Levounis, MD, MA Chair Department of Psychiatry Rutgers New Jersey Medical School Rutgers New Jersey Medical School Fundamentals of Addiction Medicine Summer Series Newark, NJ July 24, 2013

More information

Fraud, Waste and Abuse

Fraud, Waste and Abuse Fraud, Waste and Abuse CT - Fraud Hotline submitted by Connecticut The Fraud Hotline at the Department of Social Services (DSS) is a proactive approach to handling complaints regarding fraud and abuse

More information

Opioid treatment recommendations for acute pain:

Opioid treatment recommendations for acute pain: Opioid treatment recommendations for acute pain: Acute Pain Recommendation 1: Opioid medications should only be used for treatment of acute pain when the severity of the pain warrants that choice and after

More information

Opioid Prescribing After Surgical Extraction of Teeth in Medicaid Patients, 2000-2010 FREE ONLINE FIRST

Opioid Prescribing After Surgical Extraction of Teeth in Medicaid Patients, 2000-2010 FREE ONLINE FIRST Opioid Prescribing After Surgical Extraction of Teeth in Medicaid Patients, 2000-2010 FREE ONLINE FIRST James A. Baker, BS 1 ; Jerry Avorn, MD 1 ; Raisa Levin, MS 1 ; Brian T. Bateman, MD, MS 1 [+] Author

More information

receiving opioid therapy for pain: Risk factors and prevention.

receiving opioid therapy for pain: Risk factors and prevention. Overdose among VA patients receiving opioid therapy for pain: Risk factors and prevention. Amy S.B. Bohnert, Ph.D. Affiliations: VA National Serious Mental Illness Treatment Resource & Evaluation Center

More information

Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013

Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013 Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013 Chairman Lee, members of the Senate Human Services Committee,

More information

Blueprint for Prescriber Continuing Education Program

Blueprint for Prescriber Continuing Education Program CDER Final 10/25/11 Blueprint for Prescriber Continuing Education Program I. Introduction: Why Prescriber Education is Important Health care professionals who prescribe extended-release (ER) and long-acting

More information

Systems Changes to Improve Opioid Prescribing. Rosemary Mehl MD Physician, Primary Care VA Boston Healthcare System

Systems Changes to Improve Opioid Prescribing. Rosemary Mehl MD Physician, Primary Care VA Boston Healthcare System Systems Changes to Improve Opioid Prescribing Rosemary Mehl MD Physician, Primary Care VA Boston Healthcare System VA Boston HealthCare System Primary care to 30,000+ veterans Boston-Lowell-Worcester-

More information

Narcotic drugs used for pain treatment Version 4.3

Narcotic drugs used for pain treatment Version 4.3 Narcotic drugs used for pain treatment Version 4.3 Strategy to restrict the pack sizes or the type of packaging available in public pharmacies. 1. Introduction The document describing the strategy of the

More information

Massachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District

Massachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District Massachusetts Substance Abuse Policy and Practices Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District November 2014 Substance Abuse and Addiction National and State opioid abuse

More information

Screening Patients for Substance Use in Your Practice Setting

Screening Patients for Substance Use in Your Practice Setting Screening Patients for Substance Use in Your Practice Setting Learning Objectives By the end of this session, participants will Understand the rationale for universal screening. Identify potential health

More information

PARTNERSHIP HEALTHPLAN RECOMMENDATIONS For Safe Use of Opioid Medications

PARTNERSHIP HEALTHPLAN RECOMMENDATIONS For Safe Use of Opioid Medications PARTNERSHIP HEALTHPLAN RECOMMENDATIONS For Safe Use of Opioid Medications Primary Care & Specialist Prescribing Guidelines Introduction Partnership HealthPlan is a County Organized Health System covering

More information

Lora McGuire MS, RN Educator and Consultant lmcguire@jjc.edu. Barriers to effective pain relief

Lora McGuire MS, RN Educator and Consultant lmcguire@jjc.edu. Barriers to effective pain relief Lora McGuire MS, RN Educator and Consultant lmcguire@jjc.edu Barriers to effective pain relief Freedom from pain is a basic human right -WHO Pain is whatever the experiencing person says it is and exists

More information

Challenges of Pain Management In the Emergency Department

Challenges of Pain Management In the Emergency Department Challenges of Pain Management In the Emergency Department Joe Johnsey MD FACEP Medical Director Emergency Services North Mississippi Medical Center Disclosures THE END Objectives So what is the issue?

More information

MOH CLINICAL PRACTICE GUIDELINES 2/2008 Prescribing of Benzodiazepines

MOH CLINICAL PRACTICE GUIDELINES 2/2008 Prescribing of Benzodiazepines MOH CLINICL PRCTICE GUIELINES 2/2008 Prescribing of Benzodiazepines College of Family Physicians, Singapore cademy of Medicine, Singapore Executive summary of recommendations etails of recommendations

More information

Prescription Opioid Use and Opioid-Related Overdose Death TN, 2009 2010

Prescription Opioid Use and Opioid-Related Overdose Death TN, 2009 2010 Prescription Opioid Use and Opioid-Related Overdose Death TN, 2009 2010 Jane A.G. Baumblatt, MD Centers for Disease Control and Prevention Epidemic Intelligence Service Officer Tennessee Department of

More information

Opioid overdose can occur when a patient misunderstands the directions

Opioid overdose can occur when a patient misunderstands the directions Facts About Opioid Overdose How Does an Overdose Occur? Opioid overdose can occur when a patient misunderstands the directions for use, accidentally takes an extra dose, or deliberately misuses a prescription

More information

Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery

Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery Marvin D. Seppala, MD Chief Medical Officer Hazelden Betty Ford Foundation This product is supported by

More information

Chronic Opioid Use: Comparison of Current Guidelines

Chronic Opioid Use: Comparison of Current Guidelines Western Occupational and Environmental Medical Association Chronic Opioid Use: Comparison of Current Guidelines INTRODUCTION Recent controversies about opioid misuse, including misuse among patients with

More information

Drug Diversion. Controlled Substance Prescribing and Diversion

Drug Diversion. Controlled Substance Prescribing and Diversion Drug Diversion Provider Presentation Controlled Substance Prescribing and Diversion Angela Wallace, R.Ph. Coastal District Inspector, PMP Law Enforcement Officer DHEC Bureau of Drug Control Presentation

More information

The Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

The Prescription Opioid and Heroin Crisis: An Epidemic of Addiction The Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation Inc. Executive Director, Physicians for Responsible Opioid Prescribing

More information

The Opioid Addiction Epidemic: How marketing and regulatory failure led to a public health crisis

The Opioid Addiction Epidemic: How marketing and regulatory failure led to a public health crisis The Opioid Addiction Epidemic: How marketing and regulatory failure led to a public health crisis Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation Inc. Executive Director, Physicians

More information

Prescription Opioid Addiction and Chronic Pain: Non-Addictive Alternatives To Treatment and Management

Prescription Opioid Addiction and Chronic Pain: Non-Addictive Alternatives To Treatment and Management Prescription Opioid Addiction and Chronic Pain: Non-Addictive Alternatives To Treatment and Management Dr. Barbara Krantz Medical Director Diplomate American Board of Addiction Medicine 1 Learning Objectives

More information

When The Long Term Use of Narcotics for Pain Management Becomes the Problem:

When The Long Term Use of Narcotics for Pain Management Becomes the Problem: Authors: David C. Randolph, M.D., Ph.D. Dr. Randolph is an active Occupational Medicine physician in Cincinnati, Ohio, in practice for over 25 years. He is the Past President of the American Academy of

More information

Prescription drug abuse trends. Minnesota s Prescription Monitoring Program. Minnesota Rural Health Conference June 25, 2013 Duluth

Prescription drug abuse trends. Minnesota s Prescription Monitoring Program. Minnesota Rural Health Conference June 25, 2013 Duluth Prescription drug abuse trends Minnesota s Prescription Monitoring Program Carol Falkowski Drug Abuse Dialogues www.drugabusedialogues.com Barbara Carter, Manager MN Board of Pharmacy www.pmp.pharmacy.state.mn.us

More information

EMERGENCY DEPARTMENT VISITS INVOLVING NARCOTIC PAIN RELIEVERS

EMERGENCY DEPARTMENT VISITS INVOLVING NARCOTIC PAIN RELIEVERS Relievers Pain Narcotic Involving Visits Department Emergency Drug Abuse Warning Network Short Report November 05, 2015 EMERGENCY DEPARTMENT VISITS INVOLVING NARCOTIC PAIN RELIEVERS AUTHORS Elizabeth H.

More information

Acute & Chronic Pain Management (requiring opioid analgesics) in Patients Receiving Pharmacotherapy for Opioid Addiction

Acute & Chronic Pain Management (requiring opioid analgesics) in Patients Receiving Pharmacotherapy for Opioid Addiction Acute & Chronic Pain Management (requiring opioid analgesics) in Patients Receiving Pharmacotherapy for Opioid Addiction June 9, 2011 Tufts Health Care Institute Program on Opioid Risk Management Daniel

More information

INFO Brief. Prescription Opioid Use: Pain Management and Drug Abuse In King County and Washington State

INFO Brief. Prescription Opioid Use: Pain Management and Drug Abuse In King County and Washington State ADAI-IB 23-3 INFO Brief Prescription Opioid Use: Pain Management and Drug Abuse In King County and Washington State O ctober 23 Caleb Banta-Green (Alcohol and Drug Abuse Institute, University of Washington),

More information

How To Get A Tirf

How To Get A Tirf Transmucosal Immediate Release Fentanyl (TIRF) Products Risk Evaluation and Mitigation Strategy (REMS) Education Program for Prescribers and Pharmacists Products Covered Under This Program Abstral (fentanyl)

More information

Treatment of Opioid Dependence: A Randomized Controlled Trial. Karen L. Sees, DO, Kevin L. Delucchi, PhD, Carmen Masson, PhD, Amy

Treatment of Opioid Dependence: A Randomized Controlled Trial. Karen L. Sees, DO, Kevin L. Delucchi, PhD, Carmen Masson, PhD, Amy Category: Heroin Title: Methadone Maintenance vs 180-Day psychosocially Enriched Detoxification for Treatment of Opioid Dependence: A Randomized Controlled Trial Authors: Karen L. Sees, DO, Kevin L. Delucchi,

More information

Protecting your employees, physicians and you.

Protecting your employees, physicians and you. Protecting your employees, physicians and you. Opioid abuse is being talked about every day. Modern Medical has a solution - now with real outcomes. Opioids are the most common drugs prescribed in workers

More information

MEDICAL ASSISTANCE BULLETIN

MEDICAL ASSISTANCE BULLETIN ISSUE DATE September 4, 2015 SUBJECT EFFECTIVE DATE September 9, 2015 MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Opiate Dependence Treatments, Oral Buprenorphine Agents - Pharmacy

More information

WHAT WE KNOW. Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE

WHAT WE KNOW. Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE WHAT WE KNOW The misuse and abuse of prescription drugs has become a leading cause of harm among New Hampshire adults,

More information

Prescription Drug Monitoring Program Center of Excellence at Brandeis

Prescription Drug Monitoring Program Center of Excellence at Brandeis Prescription Drug Monitoring Program Center of Excellence at Brandeis Notes from the Field NF 4.1 Using PDMPs to Improve Medical Care: Washington State s Data Sharing Initiative with Medicaid and Workers

More information

MEDICAL ASSISTANCE BULLETIN

MEDICAL ASSISTANCE BULLETIN ISSUE DATE SUBJECT EFFECTIVE DATE MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Opiate Dependence Treatments Pharmacy Service Leesa M. Allen, Deputy Secretary Office of Medical

More information

Acute Pain Management in the Opioid Dependent Patient. Maripat Welz-Bosna MSN, CRNP-BC

Acute Pain Management in the Opioid Dependent Patient. Maripat Welz-Bosna MSN, CRNP-BC Acute Pain Management in the Opioid Dependent Patient Maripat Welz-Bosna MSN, CRNP-BC Relieving Pain in America (IOM) More then 116 Million Americans have pain the persists for weeks to years $560-635

More information

Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas

Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas David Lakey, MD Commissioner, Department of State Health Services Lauren Lacefield Lewis Assistant Commissioner,

More information

The TIRF REMS Access program is a Food and Drug Administration (FDA) required risk management program

The TIRF REMS Access program is a Food and Drug Administration (FDA) required risk management program Subject: Important Drug Warning Announcement of a single shared REMS (Risk Evaluation and Mitigation Strategy) program for all Transmucosal Immediate Release Fentanyl (TIRF) products due to the potential

More information

PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE

PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE May 19, 2012 National Association Boards of Pharmacy Annual Meeting Gil Kerlikowske, Director White House Office of National Drug Control Policy ONDCP

More information

EXPLORING NALOXONE UPTAKE AND USE PUBLIC MEETING July 01 02, 2015 Fred Wells Brason II fbrason@projectlazarus.org

EXPLORING NALOXONE UPTAKE AND USE PUBLIC MEETING July 01 02, 2015 Fred Wells Brason II fbrason@projectlazarus.org EXPLORING NALOXONE UPTAKE AND USE PUBLIC MEETING July 01 02, 2015 Fred Wells Brason II fbrason@projectlazarus.org Disclosures Project Lazarus Zogenix Charitable Contribution 2015 Kaléo Charitable Contribution

More information

Palmer MacKie, MD MS Director, Integrative Pain Program, Eskenazi Department of Medicine, IUSOM

Palmer MacKie, MD MS Director, Integrative Pain Program, Eskenazi Department of Medicine, IUSOM Palmer MacKie, MD MS Director, Integrative Pain Program, Eskenazi Department of Medicine, IUSOM Attorney General s Prescription Drug Abuse Task Force Member AIT Laboratories Advisory Board In 2009, 44%

More information

Bending the Prescription Opioid Dosing and Mortality Curves: Impact of the Washington State Opioid Dosing Guideline

Bending the Prescription Opioid Dosing and Mortality Curves: Impact of the Washington State Opioid Dosing Guideline AMERICAN JOURNAL OF INDUSTRIAL MEDICINE 55:325 331 (2012) Bending the Prescription Opioid Dosing and Mortality Curves: Impact of the Washington State Opioid Dosing Guideline Gary M. Franklin, MD, MPH,

More information

Cincinnati Christian University Drug Abuse Prevention Program

Cincinnati Christian University Drug Abuse Prevention Program Cincinnati Christian University Drug Abuse Prevention Program Cincinnati Christian University maintains that our bodies are created by God and should be used to glorify Him. The misuse or abuse of alcohol

More information

MEDICATION ABUSE IN OLDER ADULTS

MEDICATION ABUSE IN OLDER ADULTS MEDICATION ABUSE IN OLDER ADULTS Clifford Milo Singer, MD Adjunct Professor, University of Maine, Orono ME Chief, Division of Geriatric Mental Health and Neuropsychiatry The Acadia Hospital and Eastern

More information

Protecting your employees, the physicians and you. Opioid abuse is being talked about every day. Modern Medical has a solution.

Protecting your employees, the physicians and you. Opioid abuse is being talked about every day. Modern Medical has a solution. TM Protecting your employees, the physicians and you. Opioid abuse is being talked about every day. Modern Medical has a solution. Goals of Opioid Defense Manager TM Opioids are the most common drugs prescribed

More information

Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain

Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain Division of Workers Compensation 04.01.2015 Background Opioids

More information

Understanding Your Pain

Understanding Your Pain Toll Free: 800-462-3636 Web: www.endo.com Understanding Your Pain This brochure was developed by Margo McCaffery, RN, MS, FAAN, and Chris Pasero, RN, MS, FAAN authors of Pain: Clinical Manual (2nd ed.

More information

Striking a Balance: a provider perspective. kpfeifer@chcf.org

Striking a Balance: a provider perspective. kpfeifer@chcf.org Striking a Balance: a provider perspective kpfeifer@chcf.org Beth s story 38 years old, erratically employed Counseling doesn t help Chronic low back pain after car accident 8 Vicodin/day grew to 180 mg

More information

Utah Clinical Guidelines on Prescribing Opioids for Treatment of Pain

Utah Clinical Guidelines on Prescribing Opioids for Treatment of Pain Utah Clinical Guidelines on Prescribing Opioids for Treatment of Pain Summary Version Utah Department of Health 009 David N. Sundwall, MD Executive Director Robert T. Rolfs, MD, MPH State Epidemiologist

More information

Iowa Governor s Office of Drug Control Policy

Iowa Governor s Office of Drug Control Policy Iowa Governor s Office of Drug Control Policy medicines or take them in a manner not prescribed, we increase the risk of negative effects. It is estimated that over 35 million Americans are ages 65 and

More information

How To Write An Opiate Prescription Guideline

How To Write An Opiate Prescription Guideline Guidelines for Prescription of Opioid Medications for Acute and Chronic Pain developed and adopted by the Physician Advisory Committee Adopted by the Administrator of the Oklahoma Workers' Compensation

More information

OPIOID PAIN MEDICATION Agreement and Informed Consent

OPIOID PAIN MEDICATION Agreement and Informed Consent OPIOID PAIN MEDICATION Agreement and Informed Consent I. Introduction Research and clinical experience show that opioid (narcotic) pain medications are helpful for some patients with chronic pain. The

More information

Opioid Overdose in Western Massachusetts Springfield and Western Counties compared to statewide data

Opioid Overdose in Western Massachusetts Springfield and Western Counties compared to statewide data Volume #1 October 2015 PUBLIC HEALTH ISSUE BRIEF Opioid Overdose in Western Massachusetts Springfield and Western Counties compared to statewide data October 2015 Partners for a Healthier Community, Inc.

More information

Table of Contents. I. Introduction... 2. II. Summary... 3. A. Total Drug Intoxication Deaths... 5. B. Opioid-Related Deaths... 9

Table of Contents. I. Introduction... 2. II. Summary... 3. A. Total Drug Intoxication Deaths... 5. B. Opioid-Related Deaths... 9 Table of Contents I. Introduction... 2 II. Summary... 3 III. Charts A. Total Drug Intoxication Deaths... 5 B. Opioid-Related Deaths... 9 C. Heroin-Related Deaths... 11 D. Prescription Opioid-Related Deaths...

More information

Opioid Treatment Guidelines. Denis G. Patterson, DO University of Nevada, Reno 7/15/2015

Opioid Treatment Guidelines. Denis G. Patterson, DO University of Nevada, Reno 7/15/2015 Opioid Treatment Guidelines Denis G. Patterson, DO University of Nevada, Reno 7/15/2015 Opioid Treatment Guidelines Opioid Treatment Guidelines Chronic opioid therapy to treat chronic non-cancer pain (CNCP)

More information

Substance Use: Addressing Addiction and Emerging Issues

Substance Use: Addressing Addiction and Emerging Issues MODULE 6: SUBSTANCE USE: ADDRESSING ADDICTION AND EMERGING ISSUES Substance Use: Addressing Addiction and Emerging Issues Martha C. Romney, RN, MS, JD, MPH Assistant Professor Jefferson School of Population

More information

National Poll: Chronic Pain and Drug Addiction

National Poll: Chronic Pain and Drug Addiction National Poll: Chronic Pain and Drug Addiction April 2013 Results of a New Public Opinion Poll National Poll on Chronic Pain and Drug Addiction The National Poll on Chronic Pain was conducted online in

More information